HAE
Haemonetics Corporation Earnings Dividend
$77.62
Earnings Summary
Revenue | $346.35Mn |
Net Profits | $-20.15Mn |
Net Profit Margins | -5.82% |
PE Ratio | 35.55 |
Haemonetics Corporation’s revenue jumped 4.76% since last year same period to $346.35Mn in the Q1 2026. On a quarterly growth basis, Haemonetics Corporation has generated 2.18% jump in its revenue since last 3-months.
Haemonetics Corporation’s net profit fell -134.75% since last year same period to $-20.15Mn in the Q1 2026. On a quarterly growth basis, Haemonetics Corporation has generated -145.03% fall in its net profits since last 3-months.
Haemonetics Corporation’s net profit margin fell -133.17% since last year same period to -5.82% in the Q1 2026. On a quarterly growth basis, Haemonetics Corporation has generated -144.07% fall in its net profit margins since last 3-months.
Haemonetics Corporation’s price-to-earnings ratio after this Q1 2026 earnings stands at 35.55.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 1.09 |
EPS Estimate Current Year | 1.09 |
Haemonetics Corporation’s earning per share (EPS) estimates for the current quarter stand at 1.09 - a -14.17% fall from last quarter’s estimates.
Haemonetics Corporation’s earning per share (EPS) estimates for the current year stand at 1.09.
Key Ratios
Earning Per Share (EPS) | 1.29 |
Return on Assets (ROA) | 0.06 |
Return on Equity (ROE) | 0.12 |
Haemonetics Corporation’s earning per share (EPS) jumped 4.03% since last year same period to 1.29 in the Q1 2026. This indicates that the Haemonetics Corporation has generated 4.03% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Haemonetics Corporation’s return on assets (ROA) stands at 0.06.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Haemonetics Corporation’s return on equity (ROE) stands at 0.12.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-05-20 | 1.27 | 1.29 | 1.57% |
